| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | ||||||||||||
Net Income | ||||||||||||
4,441 | 268 | -2,337 | -891 | -6,436 | 132 | -352 | 315 | 197 | 476 | 941 | 1,225 | 573 |
Income from discontinued operations, net of income tax | ||||||||||||
321 | -192 | -992 | 65 | -105 | - | - | - | - | - | - | - | - |
Income/(loss) from continuing operations | ||||||||||||
4,120 | 460 | -1,345 | -956 | -6,331 | - | - | - | - | - | - | - | - |
Adjustments to reconcile net income to cash provided by operating activities: | ||||||||||||
Distributions from and equity in losses of unconsolidated affiliates | ||||||||||||
-14 | -46 | -102 | -67 | -37 | -49 | -84 | -2 | -9 | 19 | 41 | 44 | -33 |
Depreciation and amortization | ||||||||||||
373 | 421 | 596 | 772 | 1,351 | 1,523 | 1,256 | 950 | 896 | 838 | 818 | 649 | 661 |
Accretion of asset retirement obligations | ||||||||||||
51 | 38 | 44 | - | - | - | - | - | - | - | - | - | - |
Bargain purchase gain related to GenOn acquisition | ||||||||||||
- | - | - | - | - | - | - | 296 | 0 | 0 | - | - | - |
Provision for credit losses | ||||||||||||
95 | 85 | 68 | 45 | 64 | 64 | 67 | 45 | 59 | 54 | 61 | - | 0 |
Amortization of nuclear fuel | ||||||||||||
52 | 48 | 51 | 49 | 45 | 46 | 36 | 39 | 39 | 40 | 36 | 39 | 58 |
Amortization of financing costs and debt discount/premiums | ||||||||||||
26 | 29 | 29 | 33 | 47 | -12 | -33 | 31 | 32 | 32 | 44 | 37 | 79 |
Loss on debt extinguishment, net | ||||||||||||
-51 | -44 | -49 | -142 | 10 | -25 | 15 | -9 | -58 | 0 | 0 | - | - |
Gain (Loss) on Extinguishment of Debt | ||||||||||||
- | - | - | - | - | -95 | - | - | - | - | - | - | - |
Amortization of emissions allowances and energy credits | ||||||||||||
38 | 45 | 54 | 68 | 151 | 64 | 49 | 146 | 167 | 4 | 153 | -270 | -156 |
Amortization of unearned equity compensation | ||||||||||||
20 | 25 | 35 | 10 | 39 | 42 | 38 | 41 | 28 | 30 | 26 | 26 | 19 |
(Gain)/loss on sale of assets and disposal of assets | ||||||||||||
23 | 49 | 9 | -139 | -14 | 4 | 3 | -11 | -14 | -4 | -13 | -25 | -17 |
Impairment losses | ||||||||||||
-113 | -114 | -1,614 | -751 | -4,916 | -97 | -558 | 0 | -657 | -25 | 0 | 23 | 20 |
Changes in derivative instruments | ||||||||||||
34 | 37 | -170 | 16 | 235 | -61 | 164 | 124 | -138 | -114 | -225 | -484 | 77 |
Gain on post retirement benefits curtailment | ||||||||||||
- | - | - | - | 21 | 0 | - | - | - | - | - | - | - |
Changes in deferred income taxes and liability for uncertain tax benefits | ||||||||||||
-3,353 | 5 | 13 | -12 | 1,326 | -154 | -67 | -353 | -859 | 255 | 689 | 762 | 359 |
Gain on sale of equity method investment | ||||||||||||
- | - | - | - | - | - | - | - | - | - | 128 | - | 1 |
Changes in collateral deposits in support of energy risk management activities | ||||||||||||
105 | -105 | -80 | 396 | -334 | 146 | -47 | - | - | - | - | -417 | -125 |
Gain recognized on settlement of pre-existing relationship | ||||||||||||
- | - | - | - | - | - | - | - | - | - | 31 | - | 0 |
Changes in nuclear decommissioning trust liability | ||||||||||||
37 | 60 | 11 | 41 | -2 | 19 | 15 | 37 | 20 | 34 | 26 | 34 | 32 |
GenOn settlement, net of insurance proceeds | ||||||||||||
0 | 63 | 0 | 0 | - | - | - | - | - | - | - | - | - |
Net loss on deconsolidation of Agua Caliente and Ivanpah projects | ||||||||||||
0 | -13 | 0 | 0 | - | - | - | - | - | - | - | - | - |
Gain on sale of discontinued operations | ||||||||||||
- | - | - | - | - | - | - | - | - | - | - | 273 | 0 |
Gain on sale of emission allowances | ||||||||||||
- | - | - | - | 24 | 0 | - | - | - | - | - | 51 | -31 |
Cash provided/(used) by changes in other working capital, net of acquisition and disposition effects: | ||||||||||||
Accounts receivable - trade | ||||||||||||
-5 | 83 | 83 | -24 | -113 | 2 | 224 | 131 | 119 | -138 | -88 | -1 | -102 |
Inventory | ||||||||||||
-22 | -31 | -143 | -60 | 59 | 245 | -11 | 172 | -145 | -91 | 83 | 5 | -38 |
Prepayments and other current assets | ||||||||||||
-29 | 41 | 187 | 120 | 21 | -36 | -25 | 26 | -59 | 51 | -26 | 7 | 22 |
Accounts payable | ||||||||||||
-177 | 113 | 44 | -59 | -180 | -12 | 275 | -132 | 9 | -261 | -176 | -31 | 49 |
Change in option premiums collected | ||||||||||||
- | - | - | - | - | - | - | - | - | - | - | -268 | 8 |
Accrued expenses and other current liabilities | ||||||||||||
-41 | -166 | -88 | -61 | -29 | -26 | -114 | 231 | -111 | -48 | 48 | -6 | 98 |
Changes in other working capital | ||||||||||||
186 | 104 | 35 | -32 | 40 | 217 | 453 | -278 | -4 | -95 | 179 | 22 | -35 |
Cash provided/(used) by continuing operations | ||||||||||||
1,405 | 1,003 | 856 | 1,437 | 1,287 | - | - | - | - | - | - | - | - |
Cash provided by discontinued operations | ||||||||||||
8 | 374 | 754 | 471 | 62 | - | - | - | - | - | - | - | - |
Net Cash Provided/(Used) by Operating Activities | ||||||||||||
1,413 | 1,377 | 1,610 | 1,908 | 1,349 | 1,510 | 1,270 | 1,149 | 1,166 | 1,623 | 2,106 | 1,479 | 1,517 |
Cash Flows from Investing Activities | ||||||||||||
Payments for acquisitions of businesses | ||||||||||||
355 | 243 | 14 | 0 | 31 | 2,936 | 494 | 81 | 377 | 1,006 | 427 | - | 0 |
Cash acquired in GenOn acquisition | ||||||||||||
- | - | - | - | - | - | - | 983 | 0 | 0 | - | - | - |
Capital expenditures | ||||||||||||
228 | 388 | 254 | 544 | 1,029 | 909 | 1,987 | 3,396 | 2,310 | 706 | 734 | 899 | 481 |
(Increase)/decrease in notes receivable | ||||||||||||
- | - | - | - | - | - | - | - | 12 | 39 | -22 | 10 | 34 |
Proceeds from Renewable Energy Grants | ||||||||||||
- | - | - | 36 | 82 | 916 | 55 | 62 | 0 | 102 | 0 | - | - |
Decrease/(increase)in restricted cash, net | ||||||||||||
- | - | - | - | - | -57 | 22 | 66 | 35 | 4 | -14 | -13 | -12 |
Decrease in restricted cash to support equity requirements for U.S. DOE funded projects | ||||||||||||
- | - | - | - | - | 206 | 26 | -164 | 215 | 0 | 0 | - | - |
Decrease in notes receivable | ||||||||||||
- | - | - | - | -18 | -25 | 11 | 24 | - | - | - | - | - |
Decrease in trust fund balances | ||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | 19 |
Purchases of emission allowances | ||||||||||||
- | - | - | - | -41 | 16 | -5 | 1 | 19 | 34 | 38 | 8 | 161 |
Net proceeds from sale of emission allowances | ||||||||||||
11 | 19 | 66 | -1 | - | - | - | - | - | - | - | 75 | 272 |
Investments in nuclear decommissioning trust fund securities | ||||||||||||
416 | 572 | 512 | - | - | - | - | - | - | - | - | 616 | 265 |
Proceeds from the sale of nuclear decommissioning trust fund securities | ||||||||||||
381 | 513 | 501 | 510 | 631 | 600 | 488 | 399 | 385 | 307 | 279 | 582 | 233 |
Proceeds from sale of assets, net of cash disposed and sale of discontinued operations, net of fees | ||||||||||||
1,294 | 1,564 | 430 | - | - | - | - | - | - | - | - | 241 | 57 |
Payments to Acquire Available-for-sale Securities | ||||||||||||
- | - | - | 551 | 629 | 619 | 514 | 436 | 406 | 341 | 305 | - | 49 |
Payments for (Proceeds from) Productive Assets | ||||||||||||
- | - | - | -241 | -27 | -203 | -13 | -137 | -7 | -43 | -6 | -14 | -2 |
Deconsolidations of Agua Caliente and Ivanpah projects | ||||||||||||
0 | 268 | 0 | 0 | - | - | - | - | - | - | - | - | - |
Net distributions from investments in unconsolidated affiliates | ||||||||||||
-91 | -39 | -57 | -33 | -395 | -103 | 0 | -25 | -66 | -23 | 278 | - | - |
Contributions to discontinued operations | ||||||||||||
-44 | -60 | 150 | -58 | - | - | - | - | - | - | - | - | - |
Proceeds from sale of equity method investment | ||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | 0 |
Equity investment in unconsolidated affiliate | ||||||||||||
- | - | - | - | - | - | - | - | - | - | - | 84 | 0 |
Other | ||||||||||||
-6 | 6 | -30 | -31 | -16 | -85 | 35 | -22 | 23 | 0 | 5 | - | 0 |
Cash (used)/provided by continuing operations | ||||||||||||
558 | 520 | 340 | -369 | -1,269 | - | - | - | - | - | - | - | - |
Cash used by discontinued operations | ||||||||||||
-2 | -725 | -979 | -388 | -259 | - | - | - | - | - | - | - | - |
Net Cash (Used)/Provided by Investing Activities | ||||||||||||
556 | -205 | -639 | -757 | -1,528 | -2,903 | -2,528 | -2,262 | -3,047 | -1,623 | -954 | -672 | -327 |
Cash Flows from Financing Activities | ||||||||||||
Purchases of securities | ||||||||||||
- | - | - | 551 | 629 | - | - | - | - | - | - | - | 49 |
Payments for share repurchase activity | ||||||||||||
1,440 | 1,250 | 0 | 0 | 437 | 39 | 25 | 0 | 430 | 180 | 500 | 185 | 353 |
Payments for preferred shares | ||||||||||||
- | - | - | 226 | 0 | 0 | - | - | - | - | - | - | - |
Payments for debt extinguishment costs | ||||||||||||
26 | 32 | 42 | 121 | 0 | - | - | - | - | - | - | - | - |
Purchase of and distributions to noncontrolling interests from subsidiaries | ||||||||||||
-2 | -16 | -30 | -27 | 47 | - | - | - | - | - | - | - | - |
Proceeds from sale of noncontrolling interests in subsidiaries | ||||||||||||
- | - | - | - | 600 | 630 | - | - | - | - | - | - | - |
Payment to settle CSF I CAGR | ||||||||||||
- | - | - | - | - | - | - | - | - | - | - | 45 | 0 |
Proceeds from issuance of common stock | ||||||||||||
3 | 21 | -2 | 1 | 1 | 21 | 16 | 0 | 2 | 2 | 2 | 9 | 7 |
Proceeds from issuance of short and long-term debt | ||||||||||||
1,916 | 1,100 | 1,178 | - | - | - | - | - | - | - | - | - | - |
Proceeds from issuance of long-term debt | ||||||||||||
- | - | - | 4,412 | 1,004 | 4,563 | 1,777 | 3,165 | 6,224 | 1,484 | 892 | 20 | 1,411 |
Net receipts from settlement of acquired derivatives that include financing elements | ||||||||||||
- | - | - | - | -14 | -9 | -267 | 68 | 83 | -137 | 79 | 43 | 0 |
Contributions to, net of distributions from, noncontrolling interest in subsidiaries | ||||||||||||
- | - | - | - | - | 189 | 531 | 347 | 29 | 50 | 50 | 50 | 0 |
Payments for term loan for funded letter of credit facility | ||||||||||||
- | - | - | - | - | - | - | - | 1,300 | 1,300 | 0 | - | - |
Decrease in restricted cash supporting funded letter of credit facility | ||||||||||||
- | - | - | - | - | - | - | - | 1,300 | -1,300 | 0 | - | - |
Payments of debt issuance costs | ||||||||||||
35 | 19 | 18 | 61 | 21 | 67 | 50 | 35 | 207 | 75 | 31 | 4 | 5 |
Repayments of long-term debt | ||||||||||||
2,571 | 1,734 | 1,884 | -5,146 | -1,362 | -3,827 | -935 | -1,260 | -5,493 | -758 | -644 | -234 | -1,819 |
Payments of dividends to common stockholders | ||||||||||||
32 | 37 | 38 | 76 | 201 | 196 | 154 | 50 | 9 | 9 | 33 | 55 | 55 |
Receivable from affiliate | ||||||||||||
0 | 26 | 125 | 0 | 0 | - | - | - | - | - | - | - | - |
Other | ||||||||||||
-4 | -4 | -8 | -7 | -22 | -18 | 0 | 0 | - | - | - | - | - |
Cash provided/(used) by continuing operations | ||||||||||||
-2,191 | -1,997 | -969 | -1,251 | -377 | - | - | - | - | - | - | - | - |
Cash provided by discontinued operations | ||||||||||||
43 | 471 | -169 | 483 | -55 | - | - | - | - | - | - | - | - |
Net Cash Provided/(Used) by Financing Activities | ||||||||||||
-2,148 | -1,526 | -1,138 | -768 | -432 | 1,265 | 1,427 | 2,099 | 33 | 651 | -343 | -487 | -814 |
Effect of exchange rate changes on cash and cash equivalents | ||||||||||||
0 | 1 | -1 | 1 | 10 | -10 | -2 | -4 | 2 | -4 | 1 | -1 | 4 |
Change in Cash from discontinued operations | ||||||||||||
49 | 120 | -394 | 566 | -252 | - | - | - | - | - | - | 43 | -25 |
Net Increase in Cash and Cash Equivalents, Funds Deposited by Counterparties and Restricted Cash | ||||||||||||
-228 | -473 | 226 | -182 | -349 | -138 | 167 | 982 | -1,846 | 647 | 810 | 362 | 355 |